TY - JOUR
T1 - Porous graphitic carbon nitrides integrated biosensor for sensitive detection of cardiac troponin I
AU - Khushaim, Walaa
AU - Peramaiah, K.
AU - Beduk, Tutku
AU - Vijjapu, Mani Teja
AU - Ilton de Oliveira Filho, Jose
AU - Huang, Kuo-Wei
AU - Mani, Verappan
AU - Salama, khaled Nabil
PY - 2022/12/1
Y1 - 2022/12/1
N2 - Early diagnosis of cardiovascular diseases (CVDs) has the potential to save millions of lives each year. Sensitive quantitative measurement of blood cardiac troponin I (cTnI) is required for early diagnosis of CVDs. Porous graphitic carbon nitride (PCN) nanomaterials integrated biosensor that detects picogram/mL concentrations of cTnI is reported. PCN is an updated version of graphitic carbon nitride (GCN) with improved porosity and electronic structure. A rapid two-step chemical method was described to synthesize PCN and gold nanoparticles functionalized PCN (PCN-AuNPs). The modification of the electrode surface with PCN materials had a significant impact on the electrochemically active surface area (EASA), interfacial electron transport, aptamer immobilization, and biosensing performance. The use of PCN nanomaterial in cTnI aptasensing resulted in a 3.2-fold increase in signal amplification. PCN-AuNPs found practically applicable in human blood serum (cTnI-spiked). Furthermore, a low-cost and user-friendly sensing platform has been demonstrated by integrating a PCN-AuNPs aptasensor, a custom-made miniaturized potentiostat, and a smartphone, which provided rapid, sensitive point-of-care (PoC) analysis of cTnI. Highly sensitive detection limit (0.01 pg/mL), rapid analysis time (2 min), and small sample volume (20 μL) are the other advantages of this nano-biosensor.
AB - Early diagnosis of cardiovascular diseases (CVDs) has the potential to save millions of lives each year. Sensitive quantitative measurement of blood cardiac troponin I (cTnI) is required for early diagnosis of CVDs. Porous graphitic carbon nitride (PCN) nanomaterials integrated biosensor that detects picogram/mL concentrations of cTnI is reported. PCN is an updated version of graphitic carbon nitride (GCN) with improved porosity and electronic structure. A rapid two-step chemical method was described to synthesize PCN and gold nanoparticles functionalized PCN (PCN-AuNPs). The modification of the electrode surface with PCN materials had a significant impact on the electrochemically active surface area (EASA), interfacial electron transport, aptamer immobilization, and biosensing performance. The use of PCN nanomaterial in cTnI aptasensing resulted in a 3.2-fold increase in signal amplification. PCN-AuNPs found practically applicable in human blood serum (cTnI-spiked). Furthermore, a low-cost and user-friendly sensing platform has been demonstrated by integrating a PCN-AuNPs aptasensor, a custom-made miniaturized potentiostat, and a smartphone, which provided rapid, sensitive point-of-care (PoC) analysis of cTnI. Highly sensitive detection limit (0.01 pg/mL), rapid analysis time (2 min), and small sample volume (20 μL) are the other advantages of this nano-biosensor.
UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-85137739299&partnerID=MN8TOARS
U2 - 10.1016/j.biosx.2022.100234
DO - 10.1016/j.biosx.2022.100234
M3 - Article
SN - 2590-1370
JO - Biosensors and Bioelectronics: X
JF - Biosensors and Bioelectronics: X
ER -